CompletedPhase 4NCT01535469
Operational Research for Cryptococcal Antigen Screening
Studying Cryptococcosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Minnesota
- Principal Investigator
- David B Meya, MMedMakerere University
- Intervention
- Fluconazole(drug)
- Enrollment
- 3049 enrolled
- Eligibility
- 14 years · All sexes
- Timeline
- 2012 – 2015
Study locations (2)
- Infectious Disease Institute, Makerere University, Kampala, Uganda
- Kampala Capital Council Authority Clinics, Kampala, Uganda
Collaborators
Infectious Diseases Institute, Uganda · Makerere University · Centers for Disease Control and Prevention
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01535469 on ClinicalTrials.govOther trials for Cryptococcosis
Additional recruiting or active studies for the same condition.